C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2011
12/22/2011	CA2802376A1 Anti-vegf antibodies and uses thereof
12/22/2011	CA2802349A1 Anti-dr4 agonist antibodies
12/22/2011	CA2802344A1 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
12/22/2011	CA2801210A1 Anti-gd2 antibodies
12/22/2011	CA2797926A1 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
12/22/2011	CA2794731A1 Anti-axl antibodies and methods of use
12/21/2011	EP2397544A1 IgG-Fc FRAGMENT AND PROCESS FOR PRODUCING SAME
12/21/2011	EP2397542A1 Modified parvovirus having enhanced anti-tumour efficacy
12/21/2011	EP2397500A1 Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
12/21/2011	EP2397499A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397498A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397497A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397496A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397495A1 Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
12/21/2011	EP2397494A1 Human antibodies that bind human TNFalpha
12/21/2011	EP2397493A1 Compositions and methods for modulating immune responses
12/21/2011	EP2397189A1 Methods of modulating immunity
12/21/2011	EP2397156A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1)pathway
12/21/2011	EP2397155A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway
12/21/2011	EP2396652A1 Antibody to cytolethal distending toxin of campylobacter jejuni
12/21/2011	EP2396416A1 Humanized anti-cd20 antibodies and methods of use
12/21/2011	EP2396410A1 Method for producing protein
12/21/2011	EP2396348A1 Methods for inducing transplantation tolerance
12/21/2011	EP2396084A1 Anti-mst1r antibodies and uses thereof
12/21/2011	EP2396034A1 Antibodies and methods for treating estrogen receptor-associated diseases
12/21/2011	EP1991584B1 Antibodies against human il-22 and uses therefor
12/21/2011	EP1800124B1 Image based quantitation of molecular translocation
12/21/2011	EP1664769B1 Assay for detecting atrial and brain natriuretic peptide prohormones
12/21/2011	EP1631591B1 Connective tissue growth factor antibodies
12/21/2011	EP1539791B1 Method for distinguishing ulcerative colitis from crohn s di sease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
12/21/2011	EP1524995B1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas
12/21/2011	EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries
12/21/2011	EP1386152B1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/21/2011	EP1266003B1 Kcnb: a potassium channel protein
12/21/2011	CN1650013B 抗汉坦病毒属病毒感染的dna疫苗 Anti-hantavirus infection dna vaccine
12/21/2011	CN102292445A 表达人源化抗体的非人转基因动物及其用途 Expression of humanized antibodies and their use of non-human transgenic animals
12/21/2011	CN102292353A 用于治疗ige介导的疾患的新组合物和方法 The new combination therapy ige-mediated disorders and methods for
12/21/2011	CN102292352A Tcr复合物免疫治疗剂 Tcr composite immunotherapeutic agent
12/21/2011	CN102292351A 结合il-13的配体 Binding ligand of il-13
12/21/2011	CN102292350A 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途 Of hemagglutinin from the influenza virus fusion peptide specific monoclonal antibodies and uses thereof
12/21/2011	CN102288754A 采用特异性多抗检测尖吻蝮蛇舌形虫循环抗原的试剂盒 Using specific polyclonal antibody detection Agkistrodon tongue worm circulating antigen kit
12/21/2011	CN102286431A 抗乙型脑炎病毒的单克隆抗体及其应用 Anti-JE virus monoclonal antibody and its application
12/21/2011	CN102286103A 莱克多巴胺单克隆抗体的制备方法及其应用 Ractopamine monoclonal antibody preparation method and its application
12/21/2011	CN102286102A 钠钾atp酶dr区特异性抗体制备方法及其治疗肾脏缺血再灌注损伤中的药物作用 Sodium and potassium atp enzyme dr district drug-specific antibodies preparation and treatment of renal ischemia-reperfusion injury
12/21/2011	CN102286101A 抗VEGF单克隆抗体Fab片段Vasculizumab及其应用 Anti-VEGF monoclonal antibody Fab fragments and its application Vasculizumab
12/21/2011	CN102286100A 一种抗金黄色葡萄球菌肠毒素B的免疫球蛋白F(ab')<sub>2</sub>及其制备方法 An anti-Staphylococcus aureus enterotoxin B immunoglobulin F (ab ') <sub> 2 </ sub> and its preparation method
12/21/2011	CN102286099A 静注巨细胞病毒人免疫球蛋白及其制备方法 Intravenous immune globulin human cytomegalovirus and its preparation method
12/21/2011	CN102286097A Synthetic pokeweed antiviral protein (PAP) antigen and antibody, and preparation method and application thereof
12/21/2011	CN102286093A 一种嗜吞噬细胞无形体抗原及含有该抗原的试剂盒 One kind of addicted phagocytes Anaplasma antigen and contain the antigen kit
12/21/2011	CN102286083A 分泌型肺炎链球菌蛋白质 Secreted proteins of Streptococcus pneumoniae
12/21/2011	CN102284070A 卵黄抗体中病毒的灭活工艺 Yolk antibodies inactivated virus technology
12/21/2011	CN101565465B 一种抗刚地弓形虫表面抗原1人源抗体Fab片段及其编码基因 An anti-Toxoplasma gondii surface antigen a human antibody Fab fragments and coding gene
12/21/2011	CN101277718B 作为长效止痛剂的能抑制NGF与TrkA受体的结合的分子 As can inhibit the binding of NGF and TrkA receptor molecules of long-acting analgesics
12/21/2011	CN101252951B 抗il-23抗体、组合物、方法和用途 Anti-il-23 antibodies, compositions, methods and uses
12/20/2011	US8080650 Pro104 antibody compositions and methods of use
12/20/2011	US8080639 Antibodies which bind specifically to activin receptor like kinase 3
12/20/2011	US8080638 Anti-interferon alpha monoclonal antibodies and methods for use
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080635 Non-functional P2X7 receptor
12/20/2011	US8080525 Peptide compositions and their use against the hepatitis C virus
12/20/2011	US8080402 Surface expression method of peptides P5 and Anal3 using the gene encoding poly-gamma-glutamate synthetase
12/20/2011	US8080382 Monitoring immunologic, hematologic and inflammatory diseases
12/20/2011	US8080254 OB fusion protein compositions and methods
12/20/2011	US8080247 Anti-IL-12 antibodies
12/20/2011	US8080245 Anti-pathogen immunoadhesins
12/20/2011	US8080242 Anti-HPA
12/20/2011	CA2329754C Peptide composition as immunogen for the treatment of allergy
12/20/2011	CA2321161C Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2011	CA2202028C Tie-2 ligands, methods of making and uses thereof
12/15/2011	WO2011156694A2 Enrichment and purification of infectious prion proteins
12/15/2011	WO2011156639A1 Eiiia and eiiib segments of fibronectin regulate stem cell fate
12/15/2011	WO2011156617A2 Anti-egfr antibodies
12/15/2011	WO2011156356A1 Dimeric vstm3 fusion proteins and related compositions and methods
12/15/2011	WO2011156252A2 Sulfation of wnt pathway proteins
12/15/2011	WO2011156073A1 Removal of protein aggregates from biopharmaceutical preparations using calcium phosphate salts
12/15/2011	WO2011155607A1 Anti-tim-3 antibody
12/15/2011	WO2011155579A1 ANTI-Trop-2 ANTIBODY
12/15/2011	WO2011154908A1 Manipulation of hsp70 and ire1alpha protein interactions
12/15/2011	WO2011154705A1 Annexin 1 antibody
12/15/2011	WO2011154615A1 Method for isolating cd34+ hematopoietic stem cells, natural killer cells and regulatory t lymphocytes from a sample of human umbilical cord blood by using an anti-gd3 antibody, as well as compositions thereof
12/15/2011	WO2011154485A1 Treating cancer by modulating mammalian sterile 20-like kinase 3
12/15/2011	WO2011154453A1 Antibodies against human cd38
12/15/2011	WO2011153592A1 Therapeutic molecules
12/15/2011	WO2011106300A3 Anti-angiogenesis therapy for the treatment of ovarian cancer
12/15/2011	WO2011098424A3 Treatment of a metabolic disorder
12/15/2011	WO2011080314A3 Novel modulators of trail signalling
12/15/2011	WO2011008770A3 Methods for inhibiting yellow color and peroxide formation in a composition
12/15/2011	US20110307964 Mouse having human leukemic stem cell and leukemic non-stem cell amplified therein, and method for production thereof
12/15/2011	US20110306756 Prevention and Treatment of Amyloidogenic Disease
12/15/2011	US20110306753 Method for Increasing Protein Expression in Cells
12/15/2011	US20110306551 Modification of Factor VIII
12/15/2011	US20110306513 Novel biomarker for liver cancer and applications for same
12/15/2011	US20110306507 Method and tools for prognosis of cancer in her2+partients
12/15/2011	US20110306057 Phosphorylated RalA
12/15/2011	US20110306049 Method for detecting gynecologic cancer
12/15/2011	US20110306044 Delta3, fthma-070, tango85, tango77, spoil, neokine, tango129, and integrin alpha subunit protein and nucleic acid molecules and uses thereof
12/15/2011	US20110306040 Cpg receptor (cpg-r) and methods relating thereto
12/15/2011	US20110305749 HIV-1 Envelope Polypeptides for HIV Vaccine
12/15/2011	US20110305723 Molecular Antigen Array
12/15/2011	US20110305715 Antibodies to 3-hydroxycotinine and methods of use thereof

1 ... 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 ... 1494